Quite stable bottom 10 COVID VACCINE STOCKS with only DVAX climbing out and replaced by Translate Bio whose return fell from 138% to 100% since March 1.
Generex Bio remains at the bottom with a loss of 55% since March 1. Its numbers are poor based on the March 1 selected date as it had just popped up to $1.41 and then went straight back down.
Emergent Bio had the best week of the group with a strong close on Friday--going from a 62% return to 101%. The only other one of these stocks with a positive week was Adaptive Bio which went from a 29% to a 33% return.
No comments:
Post a Comment